CD4 and rheumatoid arthritis: However, the loss of SOCS3 in CD4+ T cells promotes anti-inflammatory cytokines, such as interleukin 10 and transforming growth factor-beta 1, and suppresses inflammatory responses29, suggesting that the decreased expression of SOCS3 itself may be beneficial for controlling RA.